Lower margin of Ranbaxy is an opportunity: Sun Pharma

PUBLISHED ON: April 9, 2014 | Duration: 10 min, 33 sec

   
loading..
Speaking to NDTV Profit, Sun Pharma chairman Israel Makov said the acquisition would be an opportunity to increase Ranbaxy's margin.
ALSO WATCH
Sensex, Nifty Open On A Flat Note

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................